Gene · 730249
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth. | Sci Rep | 2025 | 40825832 | PubTator, text mining | PubMed |
| Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA. | Sci Rep | 2025 | 40825823 | PubTator, text mining | PubMed |
| ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance. | Hepatol Commun | 2025 | 40824254 | PubTator, text mining | PubMed |
| m6A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. | Adv Sci (Weinh) | 2025 | 40801445 | PubTator, text mining | PubMed |
| Measurements of soldier head capsules of cuticular hydrocarbon phenotypes of Reticulitermes (Blattodea: Heterotermitidae) from Northern California identify morphologically cryptic and sibling species. | J Econ Entomol | 2025 | 40797288 | PubTator, text mining | PubMed |
| C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension. | Commun Biol | 2025 | 40796654 | PubTator, text mining | PubMed |
| Overexpression of CAD in stomach adenocarcinoma tissues and its clinical significance. | Semin Oncol | 2025 | 40795601 | PubTator, text mining | PubMed |
| Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice. | bioRxiv | 2025 | 40777281 | PubTator, text mining | PubMed |
| Combined metabolome and transcriptome to analyze the regulatory network of key enzymes in the synthesis of senkirkine in Emilia sonchifolia. | BMC Plant Biol | 2025 | 40751133 | PubTator, text mining | PubMed |
| PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth. | Cell Rep | 2025 | 40742808 | PubTator, text mining | PubMed |
| Physiological and Multi-Omics Analysis in Leaves of Solanum americanum in Response to Cd Toxicity. | Plants (Basel) | 2025 | 40733368 | PubTator, text mining | PubMed |
| The Antioxidant and Skin-Brightening Effects of a Novel Caffeic Acid Derivative, Caffeic Acid-3,4-Dihydroxyphenylpropanolester. | Antioxidants (Basel) | 2025 | 40722910 | PubTator, text mining | PubMed |
| De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. | EMBO Mol Med | 2025 | 40707702 | PubTator, text mining | PubMed |
| Dopamine as an endogenous regulator of innate immunity in sepsis. | Front Immunol | 2025 | 40703506 | PubTator, text mining | PubMed |
| Itaconate: A key regulator of immune responses and potential therapeutic target for autoimmune and inflammatory diseases. | Autoimmun Rev | 2025 | 40683614 | PubTator, text mining | PubMed |
| Spectroscopic method for measuring activity of cis-aconitate decarboxylase, an important metabolic regulator of immune responses. | Anal Biochem | 2025 | 40653293 | PubTator, text mining | PubMed |
| Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance. | Cell Death Dis | 2025 | 40645971 | PubTator, text mining | PubMed |
| Nanoparticles of silver and titanium can increase temozolomide sensitivity against human glioblastoma: an in vitro study on apoptosis and inflammation. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40569369 | PubTator, text mining | PubMed |
| The Promise and Challenges of CAD-Assisted Diagnosis in Achalasia. | Dig Endosc | 2025 | 40566651 | PubTator, text mining | PubMed |
| Itaconate and obesity-related hormones promote tumor progression - new insights on metabolic dysfunction in early-onset colon cancer. | Front Immunol | 2025 | 40552282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/730249/papers?page=7